Marini's NeuroSmooth™ Serum Wins Top Award, Signals Shift in Aesthetic Skincare

SAN JOSE, CA – April 06, 2026 – Marini SkinSolutions®, a veteran innovator in professional skincare, has secured a prestigious industry accolade for its latest product, NeuroSmooth™. The neuropeptide-based serum was named the ‘Best Post-Procedure Serum’ of 2026 by NewBeauty Magazine, a leading authority in the aesthetics industry. The award highlights a growing trend in cosmetics: the powerful synergy between topical treatments and medical procedures, and the consumer demand for flawless, 'glass skin' results.

NeuroSmooth™ is formulated to visibly reduce pore size, refine skin texture, and diminish fine lines, functioning both as a standalone daily serum and as a needle-free companion to neurotoxin injections like Botox. This dual-purpose positioning places the product at the lucrative intersection of daily skincare and the rapidly expanding world of medical aesthetics.

The Science of 'Glass Skin'

The allure of 'glass skin'—a term describing a complexion so smooth, luminous, and clear that it appears poreless—has become a dominant beauty ideal. Marini's NeuroSmooth™ aims to deliver this coveted finish through a sophisticated formulation centered on neuropeptides. These specialized protein fragments are signaling molecules that, when applied topically, can help modulate communication pathways within the skin.

According to dermatological experts, certain neuropeptides can interfere with the nerve signals that cause minor facial muscle contractions. This mechanism, sometimes referred to as a 'topical Botox-like' effect, can lead to a visible smoothing of expression lines. However, unlike their injectable counterparts, the effect is milder, temporary, and works on the surface level. The real innovation lies in their broader benefits. Beyond relaxing fine lines, these peptides can also support collagen production and help calm inflammation, contributing to improved skin resilience and texture over time.

This is where the product’s synergy with injectables becomes clear. While neurotoxins are highly effective at addressing dynamic wrinkles caused by muscle movement, they don't directly improve surface-level skin quality like pore size or texture. A multi-center clinical study of 54 patients on NeuroSmooth™ reported significant improvements in these areas. Participants, including those using the serum alongside neuromodulator injections, noted visibly reduced pore size, measurably refined skin texture, and a noticeable reduction in redness. Impressively, these results were observed after just two weeks of use, with high patient satisfaction reported across the board.

A Strategic Play in the Booming Injectables Market

The timing for a product like NeuroSmooth™ could not be more opportune. The U.S. market for neurotoxins was valued at approximately $6.4 billion in 2024, with industry data showing over 8.7 million procedures performed annually. This figure represents a staggering 73% increase since 2019, underscoring a massive and motivated consumer base seeking to maintain a youthful appearance.

Marini SkinSolutions® has strategically positioned NeuroSmooth™ to cater directly to this demographic. By offering a clinically studied serum proven to enhance outcomes and aid recovery from injectable procedures, the company is tapping into a significant market gap. Patients investing in neurotoxins are often highly motivated to protect and prolong their results. A product that promises to accelerate recovery, reduce post-procedure redness, and improve the overall canvas of the skin is a compelling value proposition.

"Being awarded 'Best Post-Procedure Serum' is a huge honor and aligns perfectly with our study data, showing significant improvement in pore size, texture, and skin quality when alone and alongside injectable procedures," said Stuart Mohr, VP of Marketing & Clinical at Marini SkinSolutions®. "NeuroSmooth's ability to enhance results and recovery for millions of injectable patients annually is incredibly exciting."

This business strategy moves beyond simply selling a skincare product; it integrates the product into a broader aesthetic treatment plan, making it an essential component for both providers and patients.

Redefining Post-Procedure Care

The market for post-procedure skincare is competitive, with established brands offering sophisticated formulas rich in growth factors, potent antioxidants like Vitamin C, and deep hydrators like hyaluronic acid. These ingredients are critical for supporting the skin's healing process after treatments such as lasers, microneedling, and chemical peels. They focus on accelerating cell turnover, rebuilding the skin barrier, and reducing inflammation.

NeuroSmooth™ differentiates itself by specifically emphasizing its neuropeptide technology and its direct application for the neurotoxin patient. This targeted approach aligns perfectly with the modern patient's goals. Aesthetic physicians widely agree that a well-formulated topical regimen is no longer an optional add-on but a crucial element for optimizing procedural outcomes. Effective post-procedure care can significantly shorten downtime, improve patient comfort, and ultimately lead to higher satisfaction with the primary treatment.

By improving the skin's surface quality—making it smoother, brighter, and more refined—topical serums create a synergistic effect. The muscle-relaxing power of an injectable combined with the surface-perfecting ability of a high-tech serum delivers a more comprehensive and polished result than either could achieve alone.

A Legacy of Innovation

This latest achievement for Marini SkinSolutions® is consistent with the company's long-standing reputation as a pioneer in the professional skincare space. Founded in 1994, the San Jose-based company has spent over three decades pushing the boundaries of dermatological science. Its history is marked by numerous industry-first innovations, including the introduction of the patented ingredient Thymosin Beta-4 and the development of the first lipid-soluble form of Vitamin C, which enhanced the stability and delivery of the crucial antioxidant.

This deep-rooted commitment to research and efficacy provides a powerful backstory for the launch and recognition of NeuroSmooth™. It positions the product not as a fleeting trend, but as the next step in a continued legacy of science-backed skincare solutions.

"Innovation is a cornerstone of who we are and NeuroSmooth continues that legacy, delivering glass-smooth skin while simultaneously enhancing recovery post-neurotoxin injections, making it a perfect complement to every injectable procedure," stated founder Jan Marini. "We're incredibly honored to be recognized by NewBeauty readers and editors with this prestigious award." This recognition solidifies the company's role in shaping the future of an increasingly integrated aesthetic industry.